Pharma Co. Overstated Unpatented Drug's Value, Suit Says
Pharmaceutical company Assertio Inc. has been hit with a proposed class action alleging it misled investors by concealing how reliant it was on an unpatented arthritis medicine, and by overstating the...To view the full article, register now.
Already a subscriber? Click here to view full article